Mr Mark Sullivan publishes data on Pazopanib prior to nephrectomy for patients with metastatic disease

This study investigated the role of pazopanib prior to nephrectomy in patients with metastatic renal cancer. To read the publication click the JAMA Oncology logo.

 

Comments are closed